Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current options in platelet function testing.

Alan D Michelson1, Andrew L Frelinger, Mark I Furman

  • 1Center for Platelet Function Studies, Division of Cardiovascular Medicine, Department of Pediatrics and Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. michelson@platelets.org

The American Journal of Cardiology
|November 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between immature platelet count and clinical characteristics in pediatric immune thrombocytopenia.

Research and practice in thrombosis and haemostasis·2026
Same author

A minimum valency of 4 is required for robust activation of platelets in flow cytometry by multivalent nanobodies to Glycoprotein VI, C-type lectin-like receptor 2 and Platelet Endothelial Aggregation Receptor 1.

Research and practice in thrombosis and haemostasis·2025
Same author

Clinical and research methods for analysis and study of platelet populations.

Blood·2025
Same author

Association of microtubule destabilization with platelet yields in terminally differentiating hiPSC-derived megakaryocyte lines.

PloS one·2025
Same author

ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance.

Blood·2025
Same author

Protocol for assessing and visualizing cell microaggregate formation in whole blood by imaging flow cytometry.

STAR protocols·2025
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Platelet function tests monitor antiplatelet drug effectiveness in cardiovascular disease. New point-of-care tests offer improved accuracy and accessibility over traditional methods, aiding thrombosis prevention and reducing bleeding risks.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Clinical Pathology

Background:

  • Variable responses to antiplatelet therapy necessitate monitoring drug effects in cardiovascular diseases.
  • Platelet function tests aim to optimize antiplatelet dosing for thrombosis prevention while minimizing bleeding complications.
  • Traditional turbidometric platelet aggregometry, the "gold standard," has limitations including poor reproducibility and high technical demands.

Purpose of the Study:

  • To review the limitations of current platelet function testing methods.
  • To introduce newer point-of-care platelet function assays designed to overcome existing drawbacks.
  • To highlight the clinical utility of these new assays in predicting adverse cardiac events.

Main Methods:

  • Review of existing literature on platelet function testing in cardiovascular disease.

Related Experiment Videos

  • Description of novel point-of-care platelet function assays, including VerifyNow, Plateletworks, Thrombelastograph PlateletMapping System, Impact cone and plate(let) analyzer, and PFA-100.
  • Discussion of the clinical relevance and predictive value of these assays.

    • Main Results:

    • Newer platelet function assays address limitations of traditional methods, offering improved reproducibility and ease of use.
    • These point-of-care tests facilitate bedside monitoring without extensive technical expertise.
    • Platelet inhibition levels measured by new assays correlate with the prediction of major adverse cardiac events.

    Conclusions:

    • Novel platelet function tests provide a more practical and reliable approach to monitoring antiplatelet therapy.
    • These advancements are crucial for personalized antiplatelet treatment strategies in cardiovascular patients.
    • Effective monitoring using new assays can improve patient outcomes by optimizing therapy and reducing complications.